Index of Body Inflammation for Maxillofacial Surgery Purpose-to Make the Soluble Urokinase-Type Plasminogen Activator Receptor Serum Level Independent on Patient Age
Source abstract
Abstract
Background: The serum suPAR level is affected in humans by it increases with age. Therefore it makes difficult interpretation and any comparison of age varied groups. The aim of this study is to find simple way to age independent presentation of suPAR serum level for maxillofacial surgery purpose. Methods: In generally healthy patients from 15 to 59 y.o. suPAR level was tested in serum before orthognathic or minor traumatologic procedures. Five ways to make the suPAR serum level assessment independent of age are proposed. Results: One way of making suPAR levels independent of age led to the result with the same statistical distribution as in the raw suPAR serum material and this distribution is the normal. Conclusion: The simple way for suPAR serum level analysis without its dependence on patient age is calculation of the index of body inflammation understood as square root of squared suPAR serum level divided by logarithm of patient age to base 10.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Protease and Inhibitor Mechanisms · Blood Coagulation and Thrombosis Mechanisms · Cerebrovascular and Carotid Artery Diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Maxillofacial Surgery, Medical University of Lodz, 113 Żeromskiego Str., 90-549 Lodz, Poland
Department of Laboratory Diagnostics and Clinical Biochemistry, Medical University of Lodz, 251 Pomorska Str., 92-213 Lodz, Poland
Funding
Uniwersytet Medyczny w Lodzi
References (42)
Show source-provided references
1. Intra-and perioperative complications of the LeFort I osteotomy: A prospective evaluation of 1000 patients10.1097/00001665-200411000-00016 ↗
2. Incidence of maxillary sinusitis following Le fort I osteotomy: Clinical, radiographic, and endoscopic study10.1016/j.joms.2010.07.038 ↗
3. Severity and long-term complications of surgical site infections after orthognathic surgery: A retrospective study10.1038/s41598-020-68968-2 ↗
4. Eslamipour, F., Najimi, A., Tadayonfard, A., and Azamian, Z. (2017). Impact of orthognathic surgery on quality of life in patients with dentofacial deformities. Int. J. Dent., 4103905.10.1155/2017/4103905 ↗
5. Maxillary sinus haziness and facial swelling following suction drainage in the maxilla after orthognathic surgery10.1186/s40902-020-00277-0 ↗
6. Corticosteroid administration in oral and orthognathic surgery: A systematic review of the literature and meta-analysis10.1016/j.joms.2010.04.019 ↗
7. suPAR: The molecular crystal ball10.1155/2009/504294 ↗
8. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population10.1111/j.1365-2796.2010.02252.x ↗
9. Eapen, D.J., Manocha, P., Ghasemzadeh, N., Patel, R.S., Al Kassem, H., Hammadah, M., Veledar, E., Le, N.A., Pielak, T., and Thorball, C.W. (2014). Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events. J. Am. Heart Assoc., 3e001118.10.1161/JAHA.114.001118 ↗
10. Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain10.1373/clinchem.2013.203778 ↗
11. Soluble urokinase receptor and chronic kidney disease10.1056/NEJMoa1506362 ↗
12. Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients10.1016/j.jcrc.2013.08.005 ↗
13. Cellular Receptor for Urokinase Plasminogen Activator10.1016/S0021-9258(18)52382-6 ↗
14. Haupt, T.H., Rasmussen, L.J.H., Kallemose, T., Ladelund, S., Andersen, O., Pisinger, C., and Eugen-Olsen, J. (2019). Healthy lifestyles reduce suPAR and mortality in a Danish general population study. Immun. Ageing, 16.10.1186/s12979-018-0141-8 ↗
15. Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome10.1007/s10096-011-1423-7 ↗
16. Clinical application of C-reactive protein for cardiovascular disease detection and prevention10.1161/01.CIR.0000053730.47739.3C ↗
17. The intriguing role of soluble urokinase receptor in inflammatory diseases10.1080/10408363.2016.1269310 ↗
18. CRP and suPAR are differently related to anthropometry and subclinical organ damage10.1016/j.ijcard.2012.03.040 ↗
19. Stressful Life Events and Inflammation in Midlife: Comparing Associations With suPAR, CRP, and IL-610.1093/geroni/igaa057.805 ↗
20. Associations Between a New Biomarker of Elevated Chronic Inflammation and Accelerated Aging10.1093/geroni/igaa057.464 ↗
21. Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging10.1093/gerona/glaa178 ↗
22. Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population
23. Soluble urokinase plasminogen activator receptor level in individuals of advanced age10.1038/s41598-020-72377-w ↗
24. Is Le Fort I osteotomy associated with maxillary sinusitis?10.1016/j.joms.2015.10.006 ↗
25. Incidence of maxillary sinusitis following Le fort I maxillary osteotomy10.1016/0278-2391(86)90189-8 ↗
26. A pilot study assessing the incidence of chronic sinusitis following Le fort I osteotomy in maxillofacial surgery10.1097/SCS.0000000000005605 ↗
27. Time Course of Immune Response and Immunomodulation During Normal and Delayed Healing of Musculoskeletal Wounds10.3389/fimmu.2020.01056 ↗
28. The past the present and the future of face transplantation10.1097/MOT.0000000000000812 ↗
29. 3D analysis of facial asymmetry in subjects with juvenile idiopathic arthritis10.1093/rheumatology/keq329 ↗
30. Prosthetic temporomandibular joint reconstruction in a cohort of adolescent females with juvenile idiopathic arthritis10.1186/s12969-020-00453-6 ↗
31. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome10.1111/joim.12238 ↗
32. Soluble urokinase plasminogen activator receptor in one-year prediction of major adverse cardiac events in patients after first myocardial infarction treated with primary percutaneous coronary intervention
33. Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients10.1007/s11255-017-1778-5 ↗
34. Alterations of upper airway volume caused by Le Fort III osteodistraction in children10.1016/j.jcms.2020.06.007 ↗
35. Surgical complications in orbital decompression for Graves’ orbitopathy. Complicanze chirurgiche in pazienti sottoposti a decompressione orbitaria per oftalmopatia di Graves10.14639/0392-100X-1082 ↗
36. Management of infections complicating the orbitocranial approaches: Report of two cases and review of literature10.4103/2152-7806.157659 ↗
37. Malpractice claims and unintentional outcome of tonsil surgery and other standard procedures in otorhinolaryngology
38. Maxillary osteotomy complications in piezoelectric surgery compared to conventional surgical techniques: A systematic review
39. Unusual and rare complications of orthognathic surgery: A literature review10.1016/j.joms.2011.05.010 ↗
40. Les infections du site opératoire en chirurgie orthognathique et leurs facteurs de risque10.1016/j.stomax.2009.02.003 ↗
41. Prevalence of Surgical Site Infections Following Orthognathic Surgery: A Double-Blind, Randomized Controlled Trial on a 3-Day Versus 1-Day Postoperative Antibiotic Regimen10.1016/j.joms.2016.09.038 ↗
42. Maxillofacial and concomitant serious injuries: An eight-year single center experience10.1016/j.cjtee.2016.11.003 ↗